C occidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii . Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. 1 Pulmonary infection is the most common clinical manifestation and primary coc cidioidal pneumonia may account for 17% to 29% of all community-acquired pneumonia in endemic regions. 2,3 Pleural effusions have been estimated to occur in 5% to 15% of all primary pulmonary coccidioidomycosis cases and are typically present with cough, pleuritic chest pain, and dyspnea. 4,5 The underlying diagnosis of coccidioidomycosis is not always immediately apparent, however. Coccidioidesspecifi c serologic testing is not readily available at most institutions, frequently requires the assistance of a reference laboratory, recovery of the organism may require invasive diagnostic testing, and cultures represent a severe biohazard to laboratory personnel. Therefore, the etiology of pleural effusions may not be clear on initial evaluation and other diagnoses including malignancy, autoimmune diseases, and mycobacterial or fungal disease may be sought. Even after extensive examination, the cause of pleural effusions . The sensitivity and specifi city of coccidioidal serologic testing was 100% in this study. The specifi city of PCR testing was high (100%), although the overall sensitivity remained low, and was comparable to the experience of others in the clinical use of PCR for coccidioidal diagnostics. Conclusion: Contrary to prior speculation, ADA levels in pleuropulmonary coccidioidomycosis were not elevated in this study. The sensitivity and specifi city of coccidioidal serologic testing in nonserum samples remained high, but the clinical usefulness of PCR testing in pleural fl uid was disappointing and was comparable to pleural fl uid culture.CHEST 2013; 143(3):776-781